Key points are not available for this paper at this time.
You have accessJournal of UrologyStone Disease: Medical and 3%, 12%, -19% for citrate (ptrend<0.01). No significant dose associations were observed for urinary sodium, or supersaturations of calcium oxalate or calcium phosphate. Beneficiaries with a greater reduction in urinary calcium had lower incidences of subsequent stone events (1st tertile, 24.4% versus 3rd tertile, 15.4%, ptrend=0.03) by 36 months. No other significant differences in outcomes were observed with changes in urinary supersaturations of calcium oxalate or calcium phosphate. CONCLUSIONS: Higher thiazide doses are associated with greater reductions in urinary calcium, which in turn are associated with lower incidences of subsequent stone events. Download PPT Source of Funding: Supported by NIH R01DK121709 © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e419 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Ryan Hsi More articles by this author Phyllis Yan More articles by this author Kevin Smith More articles by this author Sara Best More articles by this author John Asplin More articles by this author Joseph Crivelli More articles by this author Naim Maalouf More articles by this author Vahakn Shahinian More articles by this author John Hollingsworth More articles by this author Expand All Advertisement PDF downloadLoading ...
Hsi et al. (Mon,) studied this question.